SCRN2 Antibody [Biotin]
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-77188B
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Human, Mouse, Rat
Applications
ELISA, Immunocytochemistry/ Immunofluorescence, Western Blot
Label
Biotin
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for SCRN2 Antibody [Biotin]
Immunogen
Antibody was raised against an 18 amino acid synthetic peptide near the carboxy terminus of human SCRN2. The immunogen is located within amino acids 320 - 370 of SCRN2. Amino Acid Squence: CTFGAQDPVRTLPRFQTQV
Reactivity Notes
0
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for SCRN2 Antibody [Biotin]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Immunocytochemistry/ Immunofluorescence
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Peptide affinity purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: SCRN2
Alternate Names
secernin 2, secernin-2, Ses2
Gene Symbol
SCRN2
Additional SCRN2 Products
Product Documents for SCRN2 Antibody [Biotin]
Product Specific Notices for SCRN2 Antibody [Biotin]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...